Mark Schoenberg Uro Gen Pharma Ltd. (URGN) insider trading activity

Mark Schoenberg is Chief Medical Officer of UroGen Pharma Ltd.. Currently has a direct ownership of 139,025 shares of URGN, which is worth approximately $3.38 Million. The most recent transaction as insider was on Apr 30, 2022, when has been sold 500 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 139K

6.71% 3M change

4.18% 12M change

Total Value Held $3.38 Million

Mark Schoenberg Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 30 2022	BUY Exercise of conversion of derivative security	-	500 Added 2.06%	23,721 Ordinary Shares
Jan 31 2022	SELL Open market or private sale	$10,415 $7.58 p/Share	1,374 Reduced 5.59%	23,221 Ordinary Shares
Jan 31 2022	BUY Exercise of conversion of derivative security	-	2,500 Added 9.32%	24,320 Ordinary Shares
Jan 26 2022	SELL Open market or private sale	$898 $8.09 p/Share	111 Reduced 0.5%	22,095 Ordinary Shares
Jan 26 2022	BUY Exercise of conversion of derivative security	-	209 Added 0.93%	22,206 Ordinary Shares
Nov 18 2021	BUY Open market or private purchase	$2,096 $13.1 p/Share	160 Added 0.72%	21,997 Ordinary Shares
Nov 01 2021	SELL Open market or private sale	$4,427 $17.16 p/Share	258 Reduced 1.17%	21,837 Ordinary Shares

Oct 31 2021	BUY Exercise of conversion of derivative security	-	500 Added 2.21%	22,095 Ordinary Shares
Oct 27 2021	SELL Open market or private sale	$1,746 $16.32 p/Share	107 Reduced 0.49%	21,595 Ordinary Shares
Oct 26 2021	BUY Exercise of conversion of derivative security	-	208 Added 0.95%	21,702 Ordinary Shares
Aug 02 2021	SELL Open market or private sale	$3,801 $15.64 p/Share	243 Reduced 1.12%	21,494 Ordinary Shares
Jul 31 2021	BUY Exercise of conversion of derivative security	-	500 Added 2.25%	21,737 Ordinary Shares
Jul 26 2021	SELL Open market or private sale	$1,576 $15.3 p/Share	103 Reduced 0.49%	20,821 Ordinary Shares
Jul 26 2021	SELL Exercise of conversion of derivative security	-	208 Reduced 0.98%	20,924 Ordinary Shares
Apr 30 2021	SELL Open market or private sale	$4,860 $20.0 p/Share	243 Reduced 1.14%	21,132 Ordinary Shares
Apr 30 2021	BUY Exercise of conversion of derivative security	-	500 Added 2.29%	21,375 Ordinary Shares
Apr 26 2021	SELL Open market or private sale	$1,747 $19.63 p/Share	89 Reduced 0.42%	20,875 Ordinary Shares
Apr 26 2021	BUY Exercise of conversion of derivative security	-	209 Added 0.99%	20,964 Ordinary Shares
Jan 31 2021	SELL Open market or private sale	$23,747 $22.07 p/Share	1,076 Reduced 4.93%	20,755 Ordinary Shares
Jan 31 2021	BUY Exercise of conversion of derivative security	-	2,000 Added 8.39%	21,831 Ordinary Shares
Jan 26 2021	SELL Open market or private sale	$2,212 $22.12 p/Share	100 Reduced 0.5%	19,831 Ordinary Shares
Jan 26 2021	BUY Exercise of conversion of derivative security	-	208 Added 1.03%	19,931 Ordinary Shares
Dec 04 2020	SELL Open market or private sale	$13,141 $19.85 p/Share	662 Reduced 3.25%	19,723 Ordinary Shares
Dec 04 2020	BUY Exercise of conversion of derivative security	-	1,042 Added 4.86%	20,385 Ordinary Shares
Oct 26 2020	SELL Open market or private sale	$2,116 $20.95 p/Share	101 Reduced 0.52%	19,343 Ordinary Shares

Mark Schoenberg

Chief Medical Officer

Princeton, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells URGN shares.

Notify only if

Value

Insider Trading

Get notified when an Uro Gen Pharma Ltd. insider buys or sells URGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to UroGen Pharma Ltd.

Track Activities on URGN

Account